Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Journal of Gastrointestinal Oncology|January 5, 2018
Pretreatment albumin may aid in patient selection for intrahepatic Y-90 microsphere transarterial radioembolization (TARE) for malignancies of the liverKelly P Orwat, Thomas H Beckham, Samuel Lewis Cooper, et al.Journal of Medical Imaging and Radiation Oncology|June 16, 2012
Comparison of radiation treatment delivery for pancreatic cancer: Linac intensity-modulated radiotherapy versus helical tomotherapyRobert Taylor, Krisha Opfermann, Brian D Jones, et al.International Journal of Surgery (London, England)|July 20, 2016
The impact of metabolic syndrome on outcome and response to neoadjuvant chemoradiation in locally advanced rectal cancer patientsBrandon J Anderson, Amy E Wahlquist, Elizabeth G Hill, et al.Molecular Carcinogenesis|September 3, 2013
Slug expression inhibits calcitriol-mediated sensitivity to radiation in colorectal cancerVictoria J Findlay, R Eric Moretz, Cindy Wang, et al.The American Surgeon|May 16, 2015
The impact of surgical diversion before neoadjuvant therapy for rectal cancerBrandon J Anderson, Elizabeth G Hill, Robert E Sweeney, et al.The Journal of Clinical Endocrinology and Metabolism|April 18, 2012
Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillanceDavid T Marshall, Stephen J Savage, Elizabeth Garrett-Mayer, et al.International Journal of Radiation Oncology, Biology, Physics|March 11, 2014
Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancerNestor F Esnaola, Uzair B Chaudhary, Paul O'Brien, et al.The Journal of Clinical Investigation|October 5, 2013
Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapseJoseph C Cheng, Aiping Bai, Thomas H Beckham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2019
Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331Kelly W Maloney, Meenakshi Devidas, Cindy Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2021
Favorable Trisomies and <i>ETV6-RUNX1</i> Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331Leonard A Mattano, Meenakshi Devidas, Kelly W Maloney, et al.Pageof 4